Published in J Mater Sci Mater Med on December 01, 1997
Increased response of Vero cells to PHBV matrices treated by plasma. J Mater Sci Mater Med (2007) 0.78
Synthesis and biological evaluation of PMMA/MMT nanocomposite as denture base material. J Mater Sci Mater Med (2011) 0.77
Phospholipids as implant coatings. J Mater Sci Mater Med (2007) 0.76
Fused Deposition Modeling 3D Printing for (Bio)analytical Device Fabrication: Procedures, Materials, and Applications. Anal Chem (2017) 0.75
Cellulose-based hydrogels as body water retainers. J Mater Sci Mater Med (2000) 0.75
Specific biofunctional performances of the hydroxyapatite-sodium maleate copolymer hybrid coating nanostructures evaluated by in vitro studies. J Mater Sci Mater Med (2009) 0.75
Testing the cytotoxicity of metal alloys used as magnetic prosthetic devices. J Mater Sci Mater Med (2003) 0.75
Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest (1973) 31.28
Quantification of cells cultured on 96-well plates. Anal Biochem (1989) 2.66
Inhibition of anchorage-dependent cell spreading triggers apoptosis in cultured human endothelial cells. J Cell Biol (1994) 2.63
Determination of cell number in monolayer cultures. Anal Biochem (1986) 2.43
Studies on the biocompatibility of materials: fibroblast reorganization of substratum-bound fibronectin on surfaces varying in wettability. J Biomed Mater Res (1996) 1.29
In vitro modeling of the bone/implant interface. Anat Rec (1996) 1.09
Involvement of integrins in cell survival. Cancer Metastasis Rev (1995) 1.05
Evaluation of different staining procedures for the quantification of fibroblasts cultured in 96-well plates. Anal Biochem (1991) 0.96
Fibronectin suppresses apoptosis in normal human melanocytes through an integrin-dependent mechanism. J Invest Dermatol (1997) 0.91
Fibroblast spreading and proliferation on hydrophilic and hydrophobic surfaces is related to tyrosine phosphorylation in focal contacts. J Biomater Sci Polym Ed (1995) 0.77
In vitro study of the intrinsic toxicity of synthetic surfaces to cells. J Biomed Mater Res (1994) 0.77
Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans. Br J Pharmacol (2008) 3.39
Specific suppression of the antibody response by antibodies to receptors. Proc Natl Acad Sci U S A (1972) 3.02
Specific inhibition of plaque formation to phosphorylcholine by antibody against antibody. Science (1972) 2.73
[Virus proteins. IV. Constitution of the coat protein of the fd phage]. Hoppe Seylers Z Physiol Chem (1969) 2.56
Cyclosporin A-binding protein (cyclophilin) of Neurospora crassa. One gene codes for both the cytosolic and mitochondrial forms. J Biol Chem (1988) 2.43
A quantitative-trait locus on chromosome 6p influences different aspects of developmental dyslexia. Am J Hum Genet (1999) 2.38
Regulation of immune response by autogenous antibody against receptor. Proc Natl Acad Sci U S A (1974) 2.05
Non-neuronal acetylcholine, a locally acting molecule, widely distributed in biological systems: expression and function in humans. Pharmacol Ther (1998) 1.99
Incidence and frequency or complications and management of Meckel's diverticulum. Surg Gynecol Obstet (1989) 1.98
Evidence for non-V3-specific neutralizing antibodies that interfere with gp120/CD4 binding in human immunodeficiency virus 1-infected humans. Proc Natl Acad Sci U S A (1991) 1.97
Surgical management of subfoveal choroidal neovascularization. Ophthalmology (1992) 1.84
The cholinergic 'pitfall': acetylcholine, a universal cell molecule in biological systems, including humans. Clin Exp Pharmacol Physiol (1999) 1.68
Specific suppression of immune responses. Science (1973) 1.67
Macroglobulin structure: homology of mu and gamma heavy chains of human immunoglobulins. Science (1969) 1.64
Neonatal tolerance induced by antibody against antigen-specific receptor. Science (1974) 1.61
Superoxide flux in endothelial cells via the chloride channel-3 mediates intracellular signaling. Mol Biol Cell (2007) 1.60
CD14(++)CD16+ monocytes but not total monocyte numbers predict cardiovascular events in dialysis patients. Kidney Int (2007) 1.58
Mechanisms of cell activation by heavy metal ions. J Biomed Mater Res (1998) 1.58
Levels of virus-specific CD4 T cells correlate with cytomegalovirus control and predict virus-induced disease after renal transplantation. Transplantation (2001) 1.54
Evaluation of latent tuberculosis infection in patients with inflammatory arthropathies before treatment with TNF-alpha blocking drugs using a novel flow-cytometric interferon-gamma release assay. Rheumatology (Oxford) (2008) 1.49
The response to phosphorylcholine: dissecting an immune response. Transplant Rev (1975) 1.49
Non-neuronal acetylcholine, a signalling molecule synthezised by surface cells of rat and man. Naunyn Schmiedebergs Arch Pharmacol (1997) 1.47
Two major groups of neutralizing anti-gp120 antibodies exist in HIV-infected individuals. Evidence for epitope diversity around the CD4 attachment site. J Immunol (1992) 1.47
Outcome and cost analysis of scheduled versus emergency scleral buckling surgery. Ophthalmology (1992) 1.45
Molecular aspects of T- and B-cell function in uremia. Kidney Int Suppl (2001) 1.44
Suppression by autogenous complementary idiotypes: the priority of the first response. J Exp Med (1976) 1.43
A human flora-associated rat model of the breast-fed infant gut. J Pediatr Gastroenterol Nutr (2003) 1.43
Three variable-gene pools common to IgM, IgG and IgA immunoglobulins. Nature (1970) 1.41
Retained intraocular foreign bodies and endophthalmitis. Ophthalmology (1990) 1.41
Impaired cellular immune function in patients with end-stage renal failure. Nephrol Dial Transplant (1999) 1.40
Semisynthetic resorbable materials from hyaluronan esterification. Biomaterials (1998) 1.38
[Quality assurance in bariatric surgery in Germany--results of the German multicentre trial 2005 and 2006]. Zentralbl Chir (2008) 1.38
Expression of osteopontin messenger RNA and protein in rheumatoid arthritis: effects of osteopontin on the release of collagenase 1 from articular chondrocytes and synovial fibroblasts. Arthritis Rheum (2000) 1.36
PD-1 expression and IL-2 loss of cytomegalovirus- specific T cells correlates with viremia and reversible functional anergy. Am J Transplant (2008) 1.34
The non-neuronal cholinergic system of human skin. Horm Metab Res (2007) 1.34
The Non-neuronal cholinergic system: an emerging drug target in the airways. Pulm Pharmacol Ther (2001) 1.33
The aldolase-binding site of the human erythrocyte membrane is at the NH2 terminus of band 3. J Biol Chem (1981) 1.31
Generation of human pulmonary microvascular endothelial cell lines. Lab Invest (2001) 1.31
Preparation and analysis of seven major, topographically defined fragments of band 3, the predominant transmembrane polypeptide of human erythrocyte membranes. Biochemistry (1978) 1.30
Vitrectomy for premacular fibroplasia. Prognostic factors, long-term follow-up, and time course of visual improvement. Ophthalmology (1991) 1.29
[Sterno-costo-clavicular hyperostosis: a hitherto undescribed entity (author's transl)]. Dtsch Med Wochenschr (1975) 1.28
Import of cytochrome c into mitochondria. Cytochrome c heme lyase. Eur J Biochem (1987) 1.28
Interaction of metoprolol, propranolol and atenolol with concurrent administration of cimetidine. Klin Wochenschr (1982) 1.26
Dose-related effects of shock waves on rabbit tendo Achillis. A sonographic and histological study. J Bone Joint Surg Br (1998) 1.26
Clonal restriction of the immune response to phosphorylcholine. Nature (1974) 1.25
Relentless placoid chorioretinitis: A new entity or an unusual variant of serpiginous chorioretinitis? Arch Ophthalmol (2000) 1.25
Impaired cellular immune responses in chronic renal failure: evidence for a T cell defect. Kidney Int (1986) 1.23
Changes in nonosseous tissue adjacent to titanium implants. J Biomed Mater Res (1973) 1.22
Expression of Cx26, Cx32 and Cx43 gap junction proteins in normal and neoplastic human tissues. Int J Cancer (1992) 1.22
Interaction of cimetidine with metoprolol, propranolol, or atenolol. Lancet (1981) 1.22
Effects of physical configuration and chemical structure of suture materials on bacterial adhesion. A possible link to wound infection. Am J Surg (1984) 1.21
Anti-receptor antibody. II. Induction of long-term unresponsiveness in neonatal mice. J Immunol (1975) 1.19
Morphogenesis and possible precursor lesions of invasive carcinoma of the papilla of Vater: epithelial dysplasia and adenoma. Hum Pathol (1985) 1.18
T-cell activation follows Th1 rather than Th2 pattern in haemodialysis patients. Nephrol Dial Transplant (2000) 1.17
Defective expression of B7-2 (CD86) on monocytes of dialysis patients correlates to the uremia-associated immune defect. Kidney Int (2001) 1.17
Sternocostoclavicular hyperostosis: painful swelling of the sternum, clavicles, and upper ribs. Report of two new cases. Ann Intern Med (1977) 1.16
Biomaterial-induced sarcoma: A novel model to study preneoplastic change. Am J Pathol (2000) 1.15
Do we truly see what we think we see? The role of cognitive bias in pathological interpretation. J Pathol (2008) 1.15
The cloven hoof in legal medicine. Int J Legal Med (2001) 1.15
Insights into potential cellular mechanisms of cisplatin nephrotoxicity and their clinical application. Nephrol Dial Transplant (1997) 1.15
Priapism during regular haemodialysis. Lancet (1974) 1.14
Production of interleukin-6, tumor necrosis factor alpha and interleukin-10 in vitro correlates with the clinical immune defect in chronic hemodialysis patients. Kidney Int (1995) 1.12
The therapeutic monitoring of antimicrobial agents. Br J Clin Pharmacol (1999) 1.12
The biological role of non-neuronal acetylcholine in plants and humans. Jpn J Pharmacol (2001) 1.12
Pars plana vitrectomy for treatment of stage 2 macular holes. Arch Ophthalmol (1994) 1.09
Selective blockade of the antigen-receptor-mediated pathway of T cell activation in patients with impaired primary immune responses. J Clin Invest (1987) 1.09
Clonal depletion in neonatal tolerance. Science (1974) 1.08
Immune response to phosphorylcholine. III. Requirement of the Fc portion and equal effectiveness of IgG subclasses in anti-receptor antibody-induced suppression. J Immunol (1977) 1.08
Surgical management of submacular hemorrhage. A series of 47 consecutive cases. Arch Ophthalmol (1995) 1.08
Tetanus immunization and its association to hepatitis B vaccination in patients with chronic renal failure. Am J Kidney Dis (1995) 1.07
PCR testing for Treponema pallidum in paraffin-embedded skin biopsy specimens: test design and impact on the diagnosis of syphilis. J Clin Pathol (2007) 1.07
Release of non-neuronal acetylcholine from the isolated human placenta is mediated by organic cation transporters. Br J Pharmacol (2001) 1.07
Endothelialization of a non-woven silk fibroin net for use in tissue engineering: growth and gene regulation of human endothelial cells. Biomaterials (2004) 1.06
B-cell abnormalities in AIDS: stable and clonally-restricted antibody response in HIV-1 infection. Scand J Immunol (1993) 1.06
Idiotypic networks and nature of molecular mimicry: an overview. Methods Enzymol (1989) 1.05
In-vitro corrosion and wear of titanium alloys in the biological environment. Biomaterials (1996) 1.05
Comparative macrorestriction and RFLP analysis of Mycobacterium avium subsp. avium and Mycobacterium avium subsp. hominissuis isolates from man, pig, and cattle. Vet Microbiol (2006) 1.05
Expanding habitat of the imported fire ant (Solenopsis invicta): a public health concern. J Allergy Clin Immunol (2000) 1.05
Biocompatibility of glass ionomer cements. Biomaterials (1993) 1.04
Methods for allergen analysis in food: a review. Food Addit Contam (2004) 1.04
Immune response in biocompatibility. Biomaterials (1992) 1.04
Immune response to phosphorylcholine. IX. Characterization of hybridoma anti-TEPC15 antibodies. J Immunol (1982) 1.04
An immunologic network. Contemp Top Immunobiol (1980) 1.04
Haemangiopericytoma of the thyroid gland in combination with Hashimoto's disease. Virchows Arch (2004) 1.04
Albumin adsorption on metal surfaces. Biomaterials (1988) 1.04
Macrophage subpopulation differentiation by stimulation with biomaterials. J Biomed Mater Res (1997) 1.03
Current trends in biocompatibility testing. Proc Inst Mech Eng H (1998) 1.03
Microcirculatory dysfunction in sepsis: a pathogenetic basis for therapy? J Pathol (2000) 1.03
Mechanisms of polymer degradation in implantable devices. 2. Poly(DL-lactic acid). J Biomed Mater Res (1993) 1.03
Use of a collagen/elastin-membrane for the tissue engineering of dermis. Burns (1999) 1.03
Serological evidence for reactivation of EBV infection due to uraemic immunodeficiency. Nephrol Dial Transplant (1997) 1.02
The corrosion behaviour of Ti-6Al-4V, Ti-6Al-7Nb and Ti-13Nb-13Zr in protein solutions. Biomaterials (1999) 1.02
Porous gelatin hydrogels: 2. In vitro cell interaction study. Biomacromolecules (2007) 1.01
Nitrocellulose-enzyme-linked immunosorbent assay (NC-ELISA) - a sensitive technique for the rapid visual detection of both viral antigens and antibodies. J Virol Methods (1984) 1.00
Proinflammatory CD14+CD16+ monocytes are associated with subclinical atherosclerosis in renal transplant patients. Am J Transplant (2007) 1.00
Subtypes of acute postinfectious glomerulonephritis. Synopsis of clinical and pathological features. Clin Nephrol (1982) 1.00